Clinical and Biological Activity of Chemoimmunotherapy in Advanced Endometrial Adenocarcinoma: A Phase II Trial of the Big Ten Cancer Research Consortium.

Cancer Res Commun · 2022 · PMC9648489 · PMID 36388466

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In this study, we observed a difference between the ORR in pMMR/MSS tumors (71.4%) versus dMMR/MSI-H tumors (89.9%); however, this did not reach statistical significance given the low numbers of patients in the two subgroups.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.